Invention Application
- Patent Title: NOVEL COMPOUNDS AS DUAL INHIBITORS OF HISTONE METHYLTRANSFERASES AND DNA METHYLTRANSFERASES
-
Application No.: US15315326Application Date: 2015-03-30
-
Publication No.: US20170121316A1Publication Date: 2017-05-04
- Inventor: Xabier AGUIRRE ENA , Julen OYARZABAL SANTAMARINA , Felipe PRÓSPER CARDOSO , Maria Obdulia RABAL GRACIA , Juan Roberto RODRÍGUEZ MADOZ , Edurne SAN JOSÉ ENÉRIZ
- Applicant: FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- Priority: EP14382230.2 20140616
- International Application: PCT/EP2015/056860 WO 20150330
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D401/12

Abstract:
It relates to the use of compounds of formula (I′), or their pharmaceutically or veterinary acceptable salts, or their stereoisomers or mixtures thereof, as anticancer agents and as agents for generating induced pluripotent stem cells. Compounds of formula (I′), wherein R2′ is an alcoxy group, a hydrocarbon chain or a ring system, and R1, R3, and R4 are as defined herein, are dual inhibitors of histone methyltransferases and DNA methyltransferases. It also relates to the compounds of formula (I′), or their pharmaceutically or veterinary acceptable salts, or their stereoisomers or mixtures thereof, wherein R2′ is phenyl or 5- to 6-membered heteroaromatic ring, both optionally fused to another rings (i.e., compounds of formula (I)). It also relates to pharmaceutical or veterinary compositions containing compounds of formula (I).
Public/Granted literature
- US09840500B2 Compounds as dual inhibitors of histone methyltransferases and DNA methyltransferases Public/Granted day:2017-12-12
Information query